📰 Uberculosis India News
Uberculosis India News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Uberculosis India. Real-time updates on events, politics, business and more.
December 20, 2023
The study ‘One to Three’ will compare the treatment completion of daily dose of Rifapentine and Isoniazid for a month (1HP) to the weekly dose of Rifapentine and Isoniazid for three months (3HP) in persons living with HIV in Pune.
July 30, 2023
The 18-month study was undertaken by researchers from B J Government Medical College (BJGMC) and Johns Hopkins University (JHU) to assess the WHO-recommended 3HP regime among People Living with HIV/AIDS (PLHIV), children living with HIV and child contacts of pulmonary TB patients.
March 24, 2022
Tuberculosis is caused due to under-nourishment, HIV, alcohol, smoking and diabetes. This ailment disproportionately affects the financially marginalised sections of the society, and the stigma associated with this disease lead to underreporting and underdiagnosis.